newsfilter
← Latest News
Business Wire·

Cortexyme to Host Symposium at AAIC 2021

"Getting to the Root Cause of Alzheimer's Disease: An Innovative, Upstream Approach for Disease Modification" Cortexyme, Inc. (NASDAQ:CRTX), a company advancing a pivotal trial in Alzheimer's disease with top-line data expected in the fourth quarter